porcin
epidem
diarrhea
viru
pedv
enter
coronaviru
caus
high
morbid
mortal
porcin
herd
worldwid
although
inactiv
live
attenu
vaccin
extens
use
emerg
highli
virul
strain
recurr
outbreak
even
vaccin
farm
highlight
need
effect
vaccin
engin
genet
defin
live
attenu
vaccin
ration
approach
novel
vaccin
develop
line
engin
attenu
viru
base
transmiss
gastroenter
viru
tgev
genom
express
chimer
spike
protein
virul
unit
state
us
pedv
strain
viru
rtgevrsspedv
attenu
highlysensit
fivedayold
piglet
infect
anim
lose
weight
none
die
addit
viru
caus
minor
tissu
damag
compar
virul
viru
rtgevrsspedv
vaccin
candid
also
attenu
threeweekold
anim
use
evalu
protect
confer
viru
compar
protect
induc
infect
virul
pedv
us
strain
pedvnvsl
rtgevrsspedv
viru
protect
challeng
virul
pedv
strain
reduc
challeng
viru
titer
jejunum
lead
undetect
challeng
viru
rna
level
fece
rtgevrsspedv
viru
induc
humor
immun
respons
specif
pedv
includ
neutral
antibodi
altogeth
data
indic
rtgevrsspedv
promis
vaccin
candid
virul
pedv
infect
acut
infecti
diarrhea
major
caus
high
morbid
mortal
piglet
worldwid
enter
infect
anim
frequent
associ
virus
includ
rotavirus
coronavirus
cov
metagenom
analysi
diarrheic
healthi
sampl
china
found
porcin
cov
diarrheic
sampl
around
healthi
sampl
highlight
potenti
relev
cov
enter
porcin
pathogen
porcin
epidem
diarrhea
viru
pedv
found
diarrheic
sampl
agreement
import
viru
porcin
industri
worldwid
pedv
first
describ
europ
viru
sinc
remain
endem
european
porcin
herd
asian
countri
pedv
detect
highli
virul
outbreak
observ
sinc
virus
piglet
subsequ
attenu
chimer
vaccin
candid
develop
introduc
duplic
transcript
regul
sequenc
trss
previous
describ
group
attenu
vaccin
candid
confer
partial
protect
pig
challeng
virul
pedv
babi
hamster
kidney
cell
stabli
transform
gene
code
porcin
aminopeptidas
n
bhkpapn
grown
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
calf
serum
fc
mgml
select
agent
vero
cell
grown
dmem
supplement
heatinactiv
fc
us
virul
pedv
strain
pedvnvsl
genbank
access
number
kindli
provid
ceva
anim
health
recombin
virul
us
pedv
viru
rpedv
recov
infecti
cdna
engin
group
pascualiglesia
l
enjuan
unpublish
data
use
challeng
viru
anim
experi
pedv
infecti
cdna
maintain
bac
includ
pedv
sequenc
genbank
access
number
pedv
virus
recombin
tgev
virus
obtain
work
grown
vero
cell
supplement
infect
medium
dmem
supplement
tryptos
phosphat
broth
yeast
extract
trypsin
cultur
medium
suppli
daili
initi
trypsin
amount
dna
fragment
contain
gene
sequenc
virul
pedv
genbank
access
number
chemic
synthes
purchas
geneart
regensburg
germani
pgemt
plasmid
contain
nucleotid
genom
genbank
access
engin
paci
mlui
restrict
site
use
intermedi
plasmid
overlap
polymeras
chain
reaction
pcr
use
fuse
pedv
tgev
gene
sequenc
pedv
sequenc
encod
ectodomain
amplifi
use
purchas
sequenc
templat
oligonucleotid
pacsv
ggattaattaagaagggtaagttgctcattagaaataatggtaagttactaaactttggtaa
paci
restrict
site
ital
tgev
sequenc
encod
protein
transmembran
domain
endodomain
amplifi
use
intermedi
plasmid
templat
oligonucleotid
gagacatacatcaag
mlui
restrict
site
ital
case
pedv
sequenc
indic
underlin
obtain
bp
bp
pcr
product
use
templat
amplifi
oligonucleotid
pacsv
bp
pcr
product
digest
paci
mlui
clone
site
plasmid
gener
pgemtgevspedv
plasmid
plasmid
digest
paci
mlui
restrict
enzym
fragment
contain
chimer
gene
clone
site
clone
step
check
sequenc
pcr
fragment
clone
junction
mutant
sequenc
two
independ
cdna
construct
bhkpapn
cell
grown
confluenc
mm
plate
transfect
use
correspond
pbac
lipofectamin
invitrogen
carlsbad
ca
usa
accord
manufactur
specif
h
posttransfect
hpt
bhkpapn
transfect
cell
trypsin
wash
twice
dmem
plate
confluent
vero
monolay
grown
plate
one
hour
later
trypsin
ad
final
concentr
incub
period
cell
supernat
harvest
passag
rtgev
clone
limit
dilut
method
grown
titrat
previous
describ
twentyon
fivedayold
suckl
piglet
born
tgev
pedv
seroneg
sow
randomli
divid
two
group
nine
piglet
one
group
three
anim
ninepiglet
group
oral
inocul
tcid
anim
differ
rtgev
phosphat
buffer
salin
pb
three
piglet
group
mock
inocul
infect
anim
monitor
daili
detect
sign
enter
diseas
bodi
weight
determin
day
three
anim
per
group
euthan
necropsi
day
inocul
intestin
macroscop
lesion
evalu
front
mid
end
section
jejunum
collect
case
sampl
kept
frozen
subsequ
viru
titrat
stabil
rnalat
stabil
reagent
life
technolog
carlsbad
ca
usa
rna
extract
fix
zinc
formalin
fix
sigmaaldrich
st
loui
mo
usa
histopatholog
fix
jejunum
section
wash
twice
pb
store
ethanol
c
paraffin
embed
section
hematoxylineosin
stain
perform
histolog
laboratori
autopsi
path
kft
budapest
hungari
sampl
examin
zeiss
axiophot
fluoresc
microscop
determin
jejunum
damag
obtain
unbias
measur
three
fulllength
perceiv
villi
crypt
per
locat
least
two
differ
locat
per
section
per
anim
measur
villou
height
crypt
depth
vhcd
ratio
calcul
measur
twentyon
piglet
born
tgev
pedv
seroneg
sow
randomli
divid
four
group
tabl
piglet
group
oral
inocul
tcid
anim
rtgevrsspedv
pedvnvsl
respect
piglet
group
mock
inocul
three
week
immun
piglet
group
challeng
tcid
rpedv
per
anim
oral
rout
infect
anim
monitor
daili
detect
sign
enter
diseas
bodi
weight
determin
everi
day
fecal
swab
collect
day
postfirst
inocul
serum
sampl
taken
day
postimmun
saliva
sampl
collect
use
salivett
tube
sarstedt
germani
day
postfirst
inocul
three
anim
per
group
euthan
necropsi
day
postchalleng
postimmun
respect
intestin
macroscop
lesion
evalu
front
mid
end
section
jejunum
collect
case
sampl
kept
frozen
subsequ
viru
titrat
stabil
rnalat
stabil
reagent
life
technolog
rna
extract
fix
zinc
formalin
fix
sigmaaldrich
histopatholog
antibodi
induc
tgev
pedv
virus
detect
elisa
describ
briefli
elisa
perform
use
per
well
partial
purifi
tgev
pedvnvsl
rpedv
virus
antigen
bound
micropl
satur
bovin
serum
albumin
bsa
pb
h
c
incub
serial
dilut
serum
sampl
wash
buffer
bsa
pb
min
c
micropl
wash
three
time
wash
buffer
bound
antibodi
detect
incub
peroxidaseconjug
protein
goat
anti
pig
igg
fc
domain
goat
anti
pig
iga
biorad
hercul
ca
usa
dilut
pb
bsa
elisa
develop
kblue
tmb
substrat
neogen
lexington
ky
usa
min
room
temperatur
reaction
stop
h
absorb
read
nm
elisa
valu
sera
express
sampl
posit
ratio
spratio
od
sampl
od
neg
control
od
posit
control
od
neg
control
heatinactiv
sera
incub
h
c
presenc
pfu
pedv
viru
dmem
contain
fc
serial
dilut
mixtur
ad
confluent
vero
cell
plate
one
hour
incub
c
medium
remov
infect
medium
ad
h
cell
fix
formaldehyd
pb
stain
crystal
violet
solut
viru
titer
determin
neutral
index
defin
logarithm
ratio
tcid
presenc
medium
presenc
serum
sampl
total
intracellular
rna
extract
vero
cell
tissu
sampl
total
rna
purifi
rneasi
mini
kit
qiagen
hilden
germani
accord
manufactur
specif
isol
viral
rna
fecal
swab
swab
resuspend
pb
antibiot
uml
penicillinstreptomycin
gentamicin
amphotericin
b
rna
isol
solut
use
qiaamp
viral
mini
kit
qiagen
follow
manufactur
instruct
case
total
cdna
synthes
use
ng
total
rna
templat
random
hexam
highcapac
cdna
transcript
kit
life
technolog
follow
manufactur
recommend
viral
genom
region
gene
utr
nt
sequenc
case
end
overlap
pcr
perform
use
oligo
pair
describ
tabl
pcr
fragment
sequenc
use
specif
oligonucleotid
pedv
genom
rna
grna
level
measur
rtqpcr
analysi
use
custom
taqman
assay
detect
conserv
region
taqman
probe
ggcttactggtgttmgb
forward
primer
revers
primer
tgev
grna
evalu
use
custom
taqman
assay
set
laboratori
porcin
gusb
gene
taqman
code
use
refer
housekeep
gene
sinc
express
remain
constant
infect
cell
compar
noninfect
cell
data
shown
data
acquir
virus
realtim
pcr
system
appli
biosystem
foster
citi
ca
usa
analyz
softwar
rel
quantif
perform
use
method
experi
data
analysi
miqe
minimum
inform
public
quantit
realtim
pcr
experi
guidelin
compliant
revers
size
bp
twotail
unpair
student
test
use
analyz
differ
mean
valu
group
result
express
mean
standard
deviat
mean
p
valu
consid
signific
chimer
protein
spedvtgev
design
n
terminu
protein
contain
expos
domain
pedv
protein
virul
us
strain
figur
includ
epitop
recogn
neutral
antibodi
heptadrepeat
domain
aa
cterminu
protein
enteropathogen
tgev
viru
includ
transmembran
domain
cterminu
aa
chimer
protein
clone
tgev
infecti
cdna
replac
tgev
protein
rtgevspedv
figur
addit
chimer
spedvtgev
protein
clone
infecti
cdna
attenu
tgev
contain
duplic
transcript
regul
sequenc
trss
engin
uniqu
restrict
site
rs
avoid
overlap
consecut
gene
rtgevrsspedv
figur
recombin
virus
rtgevspedv
rtgevrsspedv
recov
transfect
vero
cell
wildtyp
attenu
cdna
respect
virus
requir
trypsin
effici
infect
vero
cell
form
syncytia
similarli
pedv
viru
growth
kinet
cell
cultur
analyz
infect
vero
cell
two
multipl
infect
moi
moi
virus
reach
peak
titer
hpi
depend
moi
figur
nevertheless
rtgevrsspedv
viru
peak
titer
fiveto
lower
parent
rtgevspedv
viru
figur
vero
cell
wildtyp
attenu
cdna
respect
virus
requir
trypsin
effici
infect
vero
cell
form
syncytia
similarli
pedv
viru
growth
kinet
cell
cultur
analyz
infect
vero
cell
two
multipl
infect
moi
moi
virus
reach
peak
titer
hpi
depend
moi
figur
nevertheless
rtgevrsspedv
viru
peak
titer
fiveto
lower
parent
rtgevspedv
viru
figur
analyz
virul
control
rtgevspedv
attenu
rtgevrsspedv
virus
fivedayold
piglet
oral
inocul
interestingli
despit
differ
viral
titer
observ
cell
cultur
viral
titer
jejunum
infect
piglet
similar
virus
dpi
figur
dpi
rtgevspedv
titer
slightli
lower
rtgevrsspedv
viru
suggest
decreas
number
gut
epitheli
cell
avail
reinfect
piglet
inocul
parent
rtgevspedv
viru
lost
weight
infect
figur
analyz
virul
control
rtgevspedv
attenu
rtgevrsspedv
virus
fivedayold
piglet
oral
inocul
tcid
anim
interestingli
despit
differ
viral
titer
observ
cell
cultur
viral
titer
jejunum
infect
piglet
similar
virus
dpi
figur
dpi
rtgevspedv
titer
slightli
lower
rtgevrsspedv
viru
suggest
decreas
number
gut
epitheli
cell
avail
reinfect
piglet
inocul
parent
rtgevspedv
viru
lost
weight
infect
figur
die
figur
data
indic
chimer
rtgevspedv
control
viru
virul
contrast
anim
infect
rtgevrsspedv
viru
maintain
weight
figur
surviv
figur
indic
viru
attenu
interestingli
viru
shed
fece
piglet
infect
attenu
rtgevrsspedv
viru
lower
observ
anim
infect
virul
parent
rtgevspedv
viru
figur
die
figur
data
indic
chimer
rtgevspedv
control
viru
virul
contrast
anim
infect
rtgevrsspedv
viru
maintain
weight
figur
surviv
figur
indic
viru
attenu
interestingli
viru
shed
fece
piglet
infect
attenu
rtgevrsspedv
viru
lower
observ
anim
infect
virul
parent
rtgevspedv
viru
figur
agreement
observ
clinic
sign
epitheli
degener
exfoli
differ
part
jejunum
observ
anim
infect
virul
rtgevspedv
viru
accompani
inflammatori
infiltr
shorten
villi
figur
interestingli
jejunum
damag
significantli
lower
anim
infect
attenu
rtgevrsspedv
viru
figur
altogeth
data
indic
rtgevrsspedv
viru
partial
attenu
agreement
observ
clinic
sign
epitheli
degener
exfoli
differ
part
jejunum
observ
anim
infect
virul
rtgevspedv
viru
accompani
inflammatori
infiltr
shorten
villi
figur
interestingli
jejunum
damag
significantli
lower
anim
infect
attenu
rtgevrsspedv
viru
figur
altogeth
data
indic
rtgevrsspedv
viru
partial
attenu
main
concern
use
modifi
live
vaccin
base
attenu
virus
biosafeti
revers
virul
recombin
circul
strain
basi
emerg
novel
virul
pedv
strain
especi
asia
rtgevrsspedv
viru
genet
stabil
may
influenc
safeti
vaccin
candid
evalu
cell
cultur
passag
cell
cultur
viral
genom
region
compris
gene
utr
nucleotid
sequenc
chang
appear
pass
viru
compar
parent
one
strongli
suggest
engin
viru
genet
stabl
cell
cultur
address
viru
stabil
vivo
end
nt
rtgevspedv
rtgevrsspedv
virus
sequenc
use
rna
isol
jejunum
fivedayold
infect
piglet
six
day
postinfect
modif
found
parent
rtgevspedv
viru
rtgevrsspedv
viru
modif
detect
engin
tr
duplic
sequenc
figur
small
delet
point
mutat
found
e
gene
elimin
engin
fsei
restrict
site
maintain
duplic
sequenc
figur
extens
delet
observ
n
gene
revert
sequenc
wildtyp
viru
figur
chang
observ
engin
mutat
n
gene
figur
interestingli
virus
viral
rna
isol
fece
piglet
seven
day
postvaccin
see
rtgevrsspedv
viru
sequenc
modif
observ
data
strongli
suggest
rtgevrsspedv
genom
recov
piglet
may
repres
vivo
evolut
engin
viru
worth
note
tgev
attenu
similar
three
trss
duplic
duplic
n
gene
suggest
vivo
evolv
rtgevrsspedv
viru
may
still
attenu
main
concern
use
modifi
live
vaccin
base
attenu
virus
biosafeti
revers
virul
recombin
circul
strain
basi
emerg
novel
virul
pedv
strain
especi
asia
rtgevrsspedv
viru
genet
stabil
may
influenc
safeti
vaccin
candid
evalu
cell
cultur
passag
cell
cultur
viral
genom
region
compris
gene
nucleotid
sequenc
chang
appear
pass
viru
compar
parent
one
strongli
suggest
engin
viru
genet
stabl
cell
cultur
address
viru
stabil
vivo
nt
rtgevspedv
rtgevrsspedv
virus
sequenc
use
rna
isol
jejunum
fivedayold
infect
piglet
six
day
chang
observ
engin
mutat
n
gene
figur
interestingli
viral
rna
isol
fece
piglet
seven
day
postvaccin
see
rtgevrsspedv
viru
sequenc
modif
observ
data
strongli
suggest
rtgevrsspedv
genom
recov
piglet
may
repres
vivo
evolut
engin
viru
worth
note
tgev
attenu
similar
three
trss
duplic
duplic
n
gene
suggest
vivo
evolv
rtgevrsspedv
viru
may
still
attenu
pedv
infect
anim
age
although
sever
clinic
sign
agedepend
pregnant
sow
suitabl
model
evalu
effect
pedv
vaccin
candid
target
anim
neonat
piglet
lactogen
immun
import
role
protect
nevertheless
avail
cost
hous
resourc
limit
use
preliminari
vaccin
candid
trial
young
pig
model
propos
preliminari
vaccin
efficaci
trial
therefor
evalu
protect
confer
rtgevrsspedv
viru
pig
use
group
vaccin
rtgevrsspedv
viru
group
vaccin
virul
us
pedv
strain
pedvnvsl
two
group
anim
vaccin
tabl
twentyon
day
vaccin
anim
challeng
virul
recombin
pedv
strain
rpedv
tabl
expect
due
anim
age
clinic
sing
enter
diseas
diarrhea
vomit
dehydr
observ
vaccin
challeng
data
shown
nevertheless
anim
vaccin
virul
pedvnvsl
strain
show
delay
weight
gain
first
week
vaccin
compar
noninfect
anim
vaccin
rtgevrsspedv
viru
figur
similar
observ
report
virul
us
isol
data
indic
rtgevrsspedv
viru
also
attenu
piglet
viru
titer
evalu
jejunum
challeng
anim
challeng
viru
replic
effici
gut
nonvaccin
anim
figur
contrast
titer
reduc
anim
vaccin
rtgevrsspedv
pedvnvsl
virus
respect
figur
similar
result
obtain
viral
rna
presenc
evalu
reduct
accumul
pedv
rna
figur
interestingli
challeng
pedv
viru
shed
nonvaccin
anim
figur
altogeth
data
indic
challeng
viru
effici
infect
vaccin
anim
furthermor
result
indic
rtgevrsspedv
protect
anim
virul
pedv
challeng
pig
use
group
vaccin
rtgevrsspedv
viru
group
vaccin
virul
us
pedv
strain
pedvnvsl
two
group
anim
vaccin
tabl
twentyon
day
vaccin
anim
challeng
virul
recombin
pedv
strain
rpedv
tabl
expect
due
anim
age
clinic
sing
enter
diseas
diarrhea
vomit
dehydr
observ
vaccin
challeng
data
shown
nevertheless
anim
vaccin
virul
pedvnvsl
strain
show
delay
weight
gain
first
week
vaccin
compar
noninfect
anim
vaccin
rtgevrsspedv
viru
figur
similar
observ
report
virul
us
isol
data
indic
rtgevrsspedv
viru
also
attenu
piglet
figur
weight
gain
vaccin
anim
threeweekold
pig
divid
four
group
anim
two
group
vaccin
rtgevrsspedv
viru
red
virul
us
pedv
strain
pedvnvsl
green
three
week
vaccin
dpv
indic
red
nonvaccin
anim
either
mock
infect
mock
grey
challeng
virul
pedv
strain
non
vaccin
black
vaccin
anim
also
challeng
dose
nonvaccin
anim
clinic
sign
weight
observ
daili
vaccin
challeng
per
week
cours
experi
averag
daili
gain
repres
mean
six
differ
anim
error
bar
repres
standard
deviat
valu
p
valu
viru
titer
evalu
jejunum
challeng
anim
challeng
viru
replic
effici
gut
nonvaccin
anim
figur
contrast
titer
reduc
anim
vaccin
rtgevrsspedv
pedvnvsl
virus
respect
figur
similar
result
obtain
viral
rna
presenc
evalu
reduct
accumul
pedv
rna
figur
interestingli
challeng
pedv
viru
shed
nonvaccin
anim
figur
altogeth
data
indic
challeng
viru
effici
infect
vaccin
anim
furthermor
result
indic
rtgevrsspedv
protect
anim
virul
pedv
challeng
figur
weight
gain
vaccin
anim
threeweekold
pig
divid
four
group
anim
two
group
vaccin
tcid
anim
rtgevrsspedv
viru
red
virul
us
pedv
strain
pedvnvsl
green
three
week
vaccin
dpv
indic
red
nonvaccin
anim
either
mock
infect
mock
grey
challeng
tcid
anim
virul
pedv
strain
non
vaccin
black
vaccin
anim
also
challeng
dose
nonvaccin
anim
clinic
sign
weight
observ
daili
vaccin
challeng
per
week
cours
experi
averag
daili
gain
repres
mean
six
differ
anim
error
bar
repres
standard
deviat
valu
p
valu
antibodi
respons
specif
pedv
evalu
sera
vaccin
nonvaccin
anim
challeng
dpv
vaccin
elicit
pedvspecif
antibodi
higher
level
pedvnvsl
vaccin
anim
rtgevrsspedv
vaccin
one
figur
result
expect
elisa
test
develop
whole
pedv
viru
chimer
rtgevrsspedv
viru
express
pedv
protein
challeng
dpv
pedv
total
antibodi
increas
challeng
group
expect
interestingli
increas
slower
vaccin
pig
agreement
decreas
challeng
viru
replic
anim
total
antitgev
antibodi
also
evalu
elisa
anim
seroneg
time
vaccin
challeng
perform
level
tgev
antibodi
signific
group
anim
remain
seroneg
pedv
challeng
result
expect
protein
main
induc
antibodi
tgev
present
virus
use
vaccin
challeng
addit
shown
antibodi
respons
specif
pedv
evalu
sera
vaccin
nonvaccin
anim
challeng
dpv
vaccin
elicit
pedvspecif
antibodi
higher
level
pedvnvsl
vaccin
anim
rtgevrsspedv
vaccin
one
figur
result
expect
elisa
test
develop
whole
pedv
viru
chimer
rtgevrsspedv
viru
express
pedv
protein
challeng
dpv
pedv
total
antibodi
increas
challeng
group
expect
interestingli
increas
slower
vaccin
pig
agreement
decreas
challeng
viru
replic
anim
total
antitgev
antibodi
also
evalu
elisa
anim
seroneg
time
vaccin
challeng
perform
level
tgev
antibodi
signific
group
anim
remain
seroneg
pedv
challeng
result
expect
protein
main
induc
antibodi
tgev
present
virus
use
vaccin
challeng
addit
shown
crossreact
tgev
pedv
analyz
humor
respons
specif
pedv
level
pedvspecif
igg
figur
iga
figur
evalu
data
similar
obtain
total
antipedv
antibodi
demonstr
protect
pedv
infect
correl
iga
level
worth
note
iga
level
sera
vaccin
anim
challeng
significantli
reduc
compar
nonvaccin
anim
figur
strongli
suggest
challeng
viru
elicit
potent
iga
respons
gut
vaccin
anim
like
due
reduc
replic
enter
tract
correl
protect
neutral
capabl
antibodi
elicit
evalu
expect
nonvaccin
anim
induc
product
neutral
antibodi
challeng
figur
contrast
pig
vaccin
pedvnvsl
rtgevrsspedv
viru
induc
signific
level
neutral
antibodi
challeng
slightli
increas
challeng
figur
neutral
capabl
antibodi
elicit
evalu
expect
nonvaccin
anim
induc
product
neutral
antibodi
challeng
figur
contrast
pig
vaccin
pedvnvsl
rtgevrsspedv
viru
induc
signific
level
neutral
antibodi
challeng
slightli
increas
challeng
figur
neutral
antibodi
produc
vaccin
anim
viru
neutral
assay
perform
use
serum
sampl
collect
dpv
dpv
challeng
rtgevrsspedv
viru
red
pedvnvsl
green
vaccin
anim
nonvaccin
challeng
anim
black
valu
repres
neutral
index
three
differ
anim
error
bar
repres
standard
deviat
valu
altogeth
data
indic
rtgevrsspedv
viru
confer
protect
pedv
infect
young
pig
model
could
basi
effect
vaccin
candid
attenu
chimer
rtgev
viru
express
ectodomain
virul
us
pedv
protein
rtgevrsspedv
engin
vaccin
candid
pedv
evalu
young
piglet
model
system
rtgevrsspedv
viru
elicit
neutral
humor
respons
specif
pedv
fact
vaccin
anim
protect
challeng
virul
pedv
viru
attenu
live
vaccin
candid
best
option
pedv
vaccin
nonrepl
antigen
inactiv
vaccin
induc
mucos
immun
protect
tradit
attenu
live
vaccin
develop
classic
pedv
strain
consist
serial
passag
virul
viru
cell
cultur
tissu
cultur
adapt
led
attenu
vivo
vaccin
effect
control
infect
extens
use
countri
novel
pedv
strain
emerg
consequ
mani
group
develop
tradit
attenu
live
vaccin
base
novel
epidem
pedv
strain
gener
shown
passag
virul
viru
cell
cultur
requir
attenu
pedv
vivo
worth
note
rtgevrsspedv
vaccin
candid
attenu
mutat
specif
design
introduc
sever
locat
viral
genom
contrast
tradit
attenu
vaccin
contain
noncontrol
mutat
throughout
genom
figur
neutral
antibodi
produc
vaccin
anim
viru
neutral
assay
perform
use
serum
sampl
collect
dpv
dpv
challeng
rtgevrsspedv
viru
red
pedvnvsl
green
vaccin
anim
nonvaccin
challeng
anim
black
valu
repres
neutral
index
three
differ
anim
error
bar
repres
standard
deviat
valu
altogeth
data
indic
rtgevrsspedv
viru
confer
protect
pedv
infect
young
pig
model
could
basi
effect
vaccin
candid
attenu
chimer
rtgev
viru
express
ectodomain
virul
us
pedv
protein
rtgevrsspedv
engin
vaccin
candid
pedv
evalu
young
piglet
model
system
rtgevrsspedv
viru
elicit
neutral
humor
respons
specif
pedv
fact
vaccin
anim
protect
challeng
virul
pedv
viru
attenu
live
vaccin
candid
best
option
pedv
vaccin
nonrepl
antigen
inactiv
vaccin
induc
mucos
immun
protect
tradit
attenu
live
vaccin
develop
classic
pedv
strain
consist
serial
passag
virul
viru
cell
cultur
tissu
cultur
adapt
led
attenu
vivo
vaccin
effect
control
infect
extens
use
countri
novel
pedv
strain
emerg
consequ
mani
group
develop
tradit
attenu
live
vaccin
base
novel
epidem
pedv
strain
gener
shown
passag
virul
viru
cell
cultur
requir
attenu
pedv
vivo
worth
note
rtgevrsspedv
vaccin
candid
attenu
mutat
specif
design
introduc
sever
locat
viral
genom
contrast
tradit
attenu
vaccin
contain
noncontrol
mutat
throughout
genom
introduc
passag
cell
cultur
passag
vivo
may
lead
vaccin
viru
revers
virul
engin
rtgevrsspedv
vaccin
candid
advantag
replic
jejunum
infect
piglet
effici
virul
control
viru
without
caus
signific
patholog
like
lead
protect
iga
respons
inde
vaccin
anim
protect
virul
pedv
challeng
contrast
tradit
attenu
vaccin
consequ
adapt
cell
cultur
dramat
reduc
replic
enter
tract
consequ
vaccin
activ
replic
induc
good
iga
lactogen
immun
respons
recent
swine
enter
coronaviru
secov
recombin
tgev
pedv
describ
europ
secov
contain
genom
background
ident
tgev
express
protein
pedv
addit
recombin
led
extens
delet
code
sequenc
tr
tgev
gene
consequ
protein
may
express
secov
worth
note
secov
isol
diarrheic
sampl
case
suggest
virul
engin
parent
rtgevspedv
viru
resembl
recombin
secov
shown
data
virul
suckl
piglet
contrast
engin
viru
rtgevrsspedv
use
vaccin
candid
attenu
genet
differ
may
eventu
allow
discrimin
secov
rtgevrsspedv
vaccin
candid
rtgevrsspedv
viru
contain
full
pedv
gene
sequenc
ii
express
tgev
protein
iii
tgev
strain
use
engin
infecti
cdna
express
tgev
protein
rtgevrsspedv
vaccin
candid
genet
stabl
tissu
cultur
nevertheless
evolv
vivo
therefor
biosafeti
could
improv
ad
addit
safeti
guard
end
pedv
viru
genom
replicas
gene
distal
posit
attenu
mutat
introduc
duplic
sequenc
close
n
gene
figur
optim
vaccin
candid
keep
balanc
viru
replic
attenu
elicit
effici
immun
respons
